Financial Perspectives’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.36K | Hold |
6,750
| – | – | ﹤0.01% | 539 |
|
|
2025
Q1 | $6.56K | Hold |
6,750
| – | – | ﹤0.01% | 546 |
|
|
2024
Q4 | $9.99K | Hold |
6,750
| – | – | ﹤0.01% | 506 |
|
|
2024
Q3 | $14.3K | Hold |
6,750
| – | – | 0.01% | 435 |
|
|
2024
Q2 | $16.5K | Hold |
6,750
| – | – | 0.01% | 405 |
|
|
2024
Q1 | $43.7K | Hold |
6,750
| – | – | 0.02% | 293 |
|
|
2023
Q4 | $26.1K | Buy |
6,750
+3,000
| +80% | +$11.6K | 0.01% | 350 |
|
|
2023
Q3 | $8.03K | Buy |
3,750
+2,500
| +200% | +$5.35K | ﹤0.01% | 473 |
|
|
2023
Q2 | $3.81K | Hold |
1,250
| – | – | ﹤0.01% | 537 |
|
|
2023
Q1 | $3.25K | Buy |
1,250
+1,000
| +400% | +$2.6K | ﹤0.01% | 549 |
|
|
2022
Q4 | $513 | Hold |
250
| – | – | ﹤0.01% | 642 |
|
|
2022
Q3 | $1.13K | Hold |
250
| – | – | ﹤0.01% | 622 |
|
|
2022
Q2 | $1.02K | Hold |
250
| – | – | ﹤0.01% | 630 |
|
|
2022
Q1 | $1.1K | Hold |
250
| – | – | ﹤0.01% | 635 |
|
|
2021
Q4 | $2.98K | Hold |
250
| – | – | ﹤0.01% | 550 |
|
|
2021
Q3 | $4.29K | Hold |
250
| – | – | ﹤0.01% | 538 |
|
|
2021
Q2 | $4.36K | Buy |
+250
| New | +$4.36K | ﹤0.01% | 557 |
|